Orthofix Medical (OFIX) Equity Ratio (2010 - 2026)

Orthofix Medical has disclosed Equity Ratio across 17 years of filings, most recently posting 0.49 for Q1 2026.

• Quarterly Equity Ratio fell 11.84% year-over-year to 0.49 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.49 (down 11.84% YoY) and the FY2025 annual result came in at 0.53, down 6.07% from the prior year.
• Equity Ratio eased to 0.49 in Q1 2026, from 0.53 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.74 in Q3 2022 and troughed at 0.49 in Q1 2026.
• A 5-year average of 0.63 and a median of 0.63 in 2024 frame the typical range for Equity Ratio.
• Annual changes were most pronounced in 2022 — Equity Ratio climbed 5.2% — and 2024, when it retreated 13.08%.
• Tracing OFIX's Equity Ratio over 5 years: stood at 0.73 in 2022, then decreased by 11.9% to 0.65 in 2023, then slipped by 12.96% to 0.56 in 2024, then declined by 6.07% to 0.53 in 2025, then declined by 7.22% to 0.49 in 2026.
• Business Quant data shows OFIX's Equity Ratio at 0.49 in Q1 2026, 0.53 in Q4 2025, and 0.53 in Q3 2025.